Carcinogenesis

• 

  Publication Venue For

  • Correction: Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure. 2019
  • Potential Functional Variants in SMC2 and TP53 in the AURORA Pathway Genes and Risk of Pancreatic Cancer. 2019
  • Lymphocyte Telomere Length Predicts Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy. 2019
  • Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. 2018
  • Response to comments on ‘Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure’ by Farioli et al. and Oddone et al 2018
  • Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure..  39:1151-1156. 2018
  • Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival..  39:879-888. 2018
  • Cellular shear stiffness reflects progression of arsenic-induced transformation during G1..  39:109-117. 2018
  • Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility..  38:1241-1248. 2017
  • Functional variants in DCAF4 associated with lung cancer risk in European populations..  38:541-551. 2017
  • Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck..  38:504-510. 2017
  • Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx..  38:432-438. 2017
  • Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells..  38:252-260. 2017
  • TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3..  37:1041-1051. 2016
  • Effect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity. 2016
  • Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium..  37:888-896. 2016
  • Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers..  37:576-582. 2016
  • Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls..  37:280-289. 2016
  • Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer..  36:1341-1353. 2015
  • Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead..  36 Suppl 1:S254-S296. 2015
  • Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions..  36 Suppl 1:S111-S127. 2015
  • Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?.  36 Suppl 1:S203-S231. 2015
  • An integrative approach identified genes associated with drug response in gastric cancer..  36:441-451. 2015
  • Identification of a melanoma susceptibility locus and somatic mutation in TET2..  35:2097-2101. 2014
  • Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients..  35:2031-2038. 2014
  • Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage..  35:692-702. 2014
  • Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy..  35:62-68. 2014
  • Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck..  34:1551-1557. 2013
  • Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk..  34:885-892. 2013
  • Estrogen metabolism within the lung and its modulation by tobacco smoke..  34:909-915. 2013
  • Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck..  34:812-817. 2013
  • Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes..  34:770-778. 2013
  • Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility..  33:1531-1537. 2012
  • Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls..  33:828-834. 2012
  • A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck..  32:1668-1674. 2011
  • Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study..  32:507-515. 2011
  • Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis..  32:477-487. 2011
  • Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial..  32:69-73. 2011
  • A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck..  31:2082-2090. 2010
  • Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck..  31:1977-1981. 2010
  • Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk..  31:1762-1769. 2010
  • A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity..  31:1405-1411. 2010
  • A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer..  31:1251-1258. 2010
  • CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies..  31:850-857. 2010
  • ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration..  31:435-441. 2010
  • Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck..  31:222-227. 2010
  • Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass.  31:785-793. 2010
  • Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck..  30:2053-2058. 2009
  • ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis..  30:1841-1847. 2009
  • A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity..  30:1717-1721. 2009
  • Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population..  30:991-996. 2009
  • Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck..  30:997-1002. 2009
  • CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells..  30:841-850. 2009
  • Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect..  30:512-519. 2009
  • Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers..  29:2120-2125. 2008
  • Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis..  29:1560-1566. 2008
  • Polymorphisms in microRNA targets: a gold mine for molecular epidemiology..  29:1306-1311. 2008
  • Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer..  29:1184-1191. 2008
  • Dietary magnesium and DNA repair capacity as risk factors for lung cancer..  29:949-956. 2008
  • Excision repair is required for genotoxin-induced mutagenesis in mammalian cells.  29:1064-1069. 2008
  • Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta..  29:905-912. 2008
  • p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers..  29:875-879. 2008
  • TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity..  29:528-535. 2008
  • Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population..  29:342-350. 2008
  • Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression..  29:252-262. 2008
  • The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation..  28:2491-2500. 2007
  • Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck..  28:2008-2012. 2007
  • Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma..  28:1906-1913. 2007
  • Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution..  28:1794-1799. 2007
  • A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma..  28:1430-1436. 2007
  • 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant..  28:988-994. 2007
  • Cancer genomics: Integrating form and function.  28:1387-1392. 2007
  • Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women .  27:2209-2216. 2006
  • MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis..  27:2028-2033. 2006
  • Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma..  27:1894-1901. 2006
  • Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study..  27:1475-1480. 2006
  • Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells..  27:1134-1145. 2006
  • Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis..  27:748-757. 2006
  • Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population..  27:766-771. 2006
  • Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer..  27:103-111. 2006
  • Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model..  26:2196-2206. 2005
  • Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis..  26:1764-1769. 2005
  • Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck..  26:1596-1602. 2005
  • Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis..  26:741-751. 2005
  • Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer..  26:649-656. 2005
  • Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX..  25:2265-2274. 2004
  • Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck..  25:1911-1916. 2004
  • Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients..  25:1695-1700. 2004
  • Role of p53 and p38 MAP kinase in nitric oxide-induced G2/M arrest and apoptosis in the human lung carcinoma cells..  25:645. 2004
  • Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice..  25:309-315. 2004
  • Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells..  24:1871-1878. 2003
  • XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity..  24:505-509. 2003
  • Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis..  22:2005-2008. 2001
  • Erratum: Reduced expression levels of nucleotide excision repair genes in lung cancer: A case-control analysis (Carcinogenesis (2000) vol. 21 (1527-1530)).  22:1893. 2001
  • Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study..  22:1195-1199. 2001
  • Erratum: XID/ERCC2 polymorphisms and risk of head and neck cancer: A case control analysis (Carcinogenesis (2000) vol. 21 (2219-2224)).  22:363. 2001
  • XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis..  21:2219-2223. 2000
  • Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells..  21:2027-2033. 2000
  • Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats..  21:1553-1558. 2000
  • Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis..  21:1527-1530. 2000
  • Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck..  20:2125-2129. 1999
  • Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas..  20:811-815. 1999
  • Progression of hepatic neoplasia in medaka (Oryzias latipes) exposed to diethylnitrosamine.  20:933-940. 1999
  • Catechol-O-methyltransferase and breast cancer risk..  19:1943-1947. 1998
  • Estrogen treatment enhances hereditary renal tumor development in Eker rats..  19:2043-2047. 1998
  • Induction of hepatic CYP1A in channel catfish increases binding of 2-aminoanthracene to DNA in vitro and in vivo..  19:1495-1501. 1998
  • The multifaceted roles of nitric oxide in cancer..  19:711-721. 1998
  • Identification, chromosomal mapping and tissue-specific expression of hREV3 encoding a putative human DNA polymerase ζ.  19:945-949. 1998
  • Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle..  17:1511-1517. 1996
  • Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking..  15:2421-2427. 1994
  • Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung..  15:2613-2618. 1994
  • Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis..  15:2249-2254. 1994
  • Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation..  15:2183-2187. 1994
  • Preferential formation and repair of chromium-induced DNA adducts and DNA--protein crosslinks in nuclear matrix DNA..  15:1443-1450. 1994
  • Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice..  14:1167-1173. 1993
  • Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake..  14:429-434. 1993
  • Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats..  13:2205-2210. 1992
  • Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell lines..  12:1739-1744. 1991
  • Carcinogen-induced unscheduled DNA synthesis in xenotransplanted human tracheobronchial epithelium: comparison with rat tracheal epithelium..  9:467-472. 1988
  • Physicochemical characteristics and biological effects of nickel oxides..  8:305-313. 1987
  • Induction of rat kidney ornithine decarboxylase by nicotinamide without a concomitant increase in DNA synthesis..  7:175-178. 1986
  • Metabolism of 1,2-dimethylhydrazine by cultured human colon..  1:375-380. 1980
  • Gamma glutamyl transpeptidase in safrole-induced, presumptive premalignant mouse hepatocytes.  1:151-156. 1980